Blog

Ginkgo Bioworks to go public in $17.5B SPAC deal

ginkgo-bioworks-15900xx6720-4480-0-0

Ginkgo Bioworks bills itself as "the organism company," making custom microbes by programming cellular DNA. As a public firm, Ginkgo plans to continue that work, with ambitious plans to expand into "every physical goods company."

Read More